Seed
Developer of synbiotics for simulating gut microbiome
Funding snapshot
About
Developer synbiotics for simulating the gut microbiome. The company metabolomic sequencing and has developed a proprietary screening platform for the screening of host mechanistic pathways. The company claims that the probiotics developed to contain the strains having GRAS and/or QPS (Qualified Presumption of Safety) status. The strains have shown improvements in multiple markers of gastrointestinal health, cardiovascular health, and dermatological health.
Latest news
No articles yet.
Similar startups
NovaHealth AI
Clinical documentation copilot for ambulatory care networks in the US.
Statiq
Manufacturer of electric vehicle charging hardware and operator of networks
Spyne.ai
Platform offering AI-powered imaging for vehicle photography
Immuneel
Developer of T-cell therapies for the treatment of cancer